12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday’s after-market session. The company’s market cap stands…
What’s Going On With Molecular Templates Stock?
Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+ solid tumors. Molecular Templates said the findings show that MT-6402 acts uniquely from other approved checkpoint agents and was well-tolerated with no drug-related Grade 4 or Grade 5 adverse events observed. "We are excited to see objective responses in heavily pre-treated, checkpoint-experienced, head and neck cancer patients, a setting with high unmet medical need," said CEO Eric Poma.
Molecular Templates Presents Interim Data From MT-6402 Phase I Study In Patients With PD-L1+ Solid Tumors At 2024 AACR Annual Meeting
The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:MT-6402 has been well tolerated with no drug-related Grade 4 or Grade 5 adverse events observed MT-6402 acts uniquely
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Protara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday’s pre-market session. The market value of…
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.
Molecular Templates Announces First Patient Dosed In Phase 1 Trial Evaluating MT-8421, A Novel Engineered Toxin Body Targeting CTLA-4, In Advanced Solid Tumors
Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")))), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today
Molecular Templates Announces 1-For-15 Reverse Stock Split
Molecular Templates, Inc., (NASDAQ:MTEM) (the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today announced
Molecular Templates Announces Executive Leadership Changes; Jason Kim To Assume The Role Of President And Chief Financial Officer; Kristen Quigley To Assume The Role Of Chief Operating Officer
Dr. Gabriela Gruia to assume the role of interim Chief Medical Officer
Jason Kim to assume the role of President and Chief Financial Officer
Kristen Quigley to assume the role of Chief Operating Officer
Dr. Grace
$2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Ainos (NASDAQ:AIMD) shares increased by 84.9% to $1.35 during Thursday’s after-market session. At the close, Ainos’s trading…